Cannabis Strategic Ventures Valuation
Is NUGS undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6Valuation Score 0/6
Por debajo del valor justo
Muy por debajo del valor justo
Price-To-Book vs. similares
Price-To-Book vs. Industria
PM vs. Ratio Justo
Pronóstico de los analistas
Share Price vs Fair Value
What is the Fair Price of NUGS when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Por debajo del valor justo: Datos insuficientes para calcular el valor razonable de NUGS para el análisis de valoración.
Muy por debajo del valor justo: Datos insuficientes para calcular el valor razonable de NUGS para el análisis de valoración.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for NUGS?
Other financial metrics that can be useful for relative valuation.
What is NUGS's n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$404.00 |
Key Statistics | |
---|---|
Enterprise Value/Revenue | n/a |
Enterprise Value/EBITDA | n/a |
PEG Ratio | n/a |
Price to Book Ratio vs Peers
How does NUGS's PB Ratio compare to its peers?
Company | Forward PB | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 0.0002x | ||
HCAN.F Halo Collective | 0.000007x | n/a | US$150.0 |
PLXP.Q PLx Pharma Winddown | 0.000003x | n/a | US$30.0 |
CWWB.F Plant-Based Investment | 0.000003x | n/a | US$27.0 |
RVLP.Q RVL Pharmaceuticals | 0.0007x | n/a | US$11.1k |
NUGS Cannabis Strategic Ventures | n/a | n/a | US$404.0 |
Price-To-Book vs. similares: Datos insuficientes para calcular el ratio Price-To-Book de NUGS en comparación con sus homólogos para el análisis de valoración.
Price to Earnings Ratio vs Industry
How does NUGS's PE Ratio compare vs other companies in the US Pharmaceuticals Industry?
Price-To-Book vs. Industria: Datos insuficientes para calcular NUGS's Price-To-Book Ratio vs. industry for valuation analysis.
Price to Book Ratio vs Fair Ratio
What is NUGS's PB Ratio compared to its Fair PB Ratio? This is the expected PB Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PB Ratio | n/a |
Fair PB Ratio | n/a |
PM vs. Ratio Justo: Datos insuficientes para calcular NUGS's Price-To-Book Fair Ratio para el análisis de valoración.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Pronóstico de los analistas: Datos insuficientes para mostrar el pronóstico de precios.